Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an hiv+ patient population

Psychosomatic Medicine

Volumn 70, Issue 4, 2008, Pages 505-511

  Gaynes, Bradley N ^a,b   Pence, Brian Wells ^c   Eron Jr , Joseph J ^a   Miller, William C ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Anxiety; Depression; HIV; Prevalence; Psychiatric comorbidity; Substance use

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANXIETY DISORDER; ARTICLE; CAUCASIAN; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ETHNICITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RACE DIFFERENCE; STANDARD; SUBSTANCE ABUSE; SYMPTOMATOLOGY; UNITED STATES; ADDICTION; AGE; CROSS-SECTIONAL STUDY; HEALTH SURVEY; MIDDLE AGED; PSYCHOLOGIC TEST; RISK FACTOR;

ADULT; AGE FACTORS; ANXIETY DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEALTH SURVEYS; HIV SEROPOSITIVITY; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MENTAL DISORDERS; MIDDLE AGED; MOOD DISORDERS; RISK FACTORS; SOUTHEASTERN UNITED STATES; SUBSTANCE-RELATED DISORDERS;

EID: 45149099897     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31816aa0cc     Document Type: Article

References (47)

1. Sherbourne CD, Hays RD, Fleishman JA, Vitiello B, Magruder KM, Bing EG, McCaffrey D, Burnam A, Longshore D, Eggan F, Bozzette SA, Shapiro MF. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry 2000;157:248-254
2. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, Moore J. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA 2001;285:1466-1474
3. Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry 2003;54:295-306. (Pubitemid 37267859)
4. Pence BW, Miller WC, Gaynes BN, Eron JJ Jr. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007;44:159-166
5. Gordillo V, del Amo J, Soriano V, González-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-1769
6. Bagasra O, Pomerantz RJ. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Dis 1993;168:1157-1164 (Pubitemid 23317129)
7. Leserman J. The effects of stressful life events, coping, and cortisol on HIV infection. CNS Spectr 2003;8:25-30.
8. Angelino AF, Treisman GJ. Management of psychiatric disorders in patients infected with human immunodeficiency virus. Clin Infect Dis 2001;33:847-856
9. Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antide-pressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr 2005;38: 432-438
10. Bouhnik AD, Preau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther 2005;10:53-61.
11. Aral SO, O'Leary A, Baker C. Sexually transmitted infections and HIV in the southern United States: an overview. Sex Transm Dis 2006;33: S1-S5.
12. Pence BW, Gaynes BN, Whetten K, Eron JJ Jr, Ryder RW, Miller WC. Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients. J Acquir Immune Defic Syndr 2005;40: 434-444
13. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001;58:721-728
14. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001;158: 725-730
15. Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med 2003;114:573-580
16. Turner BJ, Fleishman JA, Wenger N, London AS, Burnam MA, Shapiro MF, Bing EG, Stein MD, Longshore D, Bozzette SA. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med 2001;16:625-633
17. Fairfield KM, Libman H, Davis RB, Eisenberg DM. Delays in protease inhibitor use in clinical practice. J Gen Intern Med 1999;14:395-401.
18. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005;62: 617-627 (Pubitemid 40973437)
19. Hirschfeld RM. The comorbidity of major depression and anxiety disorders: recognition and management in primary care. Prim Care Companion J Clin Psychiatry 2001;3:244-254
20. Sherbourne CD, Wells KB, Meredith LS, Jackson CA, Camp P. Comor-bid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry 1996;53: 889-895
21. DiMatteo MR, Lepper HS, Croghan TW. depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160: 2101-2107
22. Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiret-roviral therapy. Drugs 2006;66:769-789
23. Dausey DJ, Desai RA. Psychiatric comorbidity and the prevalence of HIV infection in a sample of patients in treatment for substance abuse. J Nerv Ment Dis 2003;191:10-17
24. Parienti JJ, Massari V, Descamps D, Vabret A, Bouvet E, Larouze B, Verdon R. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine-or efavirenz-based antiretroviral therapy. Clin Infect Dis 2004;38:1311-1316
25. Winiarski MG, Greene LI, Miller AL, Palmer NB, Salcedo J, Villanueva M. Psychiatric diagnoses in a sample of HIV-infected people of color in methadone treatment. Community Ment Health J 2005;41:379-391
26. First MH, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders-Research Version, Patient Edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 1990.
27. Aneshensel CS, Frerichs RR, Clark VA, Yokopenic PA. Telephone versus in-person surveys of community health status. Am J Public Health 1982;72:1017-1021
28. Aneshensel CS, Frerichs RR, Clark VA, Yokopenic PA. Measuring depression in the community: a comparison of telephone and personal interviews. Public Opin Q 1982;46:110-121
29. Simon GE, Revicki D, VonKorff M. Telephone assessment of depression severity. J Psychiatr Res 1993;27:247-252
30. Wells KB, Burnam MA, Leake B, Robins LN. Agreement between face-to-face and telephone-administered versions of the depression section of the NIMH diagnostic interview schedule. J Psychiatr Res 1988; 22:207-220
31. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons, Inc.; 2000.
32. Aina Y, Susman JL. Understanding comorbidity with depression and anxiety disorders. J Am Osteopath Assoc 2006;106:S9-S14.
33. McLaughlin TP, Khandker RK, Kruzikas DT, Tummala R. Overlap of anxiety and depression in a managed care population: prevalence and association with resource utilization. J Clin Psychiatry 2006;67:1187-1193
34. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000;160:3278-3285
35. Lydiard RB. Coexisting depression and anxiety: special diagnostic and treatment issues. J Clin Psychiatry 1991;52(Suppl):48-54.
36. Pollack MH. Comorbid anxiety and depression. J Clin Psychiatry 2005; 66(Suppl 8):22-29
37. Ostacher MJ. Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment. Psychiatr Clin North Am 2007;30:69-76.
38. Himelhoch S, Moore RD, Treisman G, Gebo KA. Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy? J Acquir Immune Defic Syndr 2004;37:1457-1463
39. Dalessandro M, Conti CM, Gambi F, Falasca K, Doyle R, Conti P, Caciagli F, Fulcheri M, Vecchiet J. Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. J Clin Psychopharmacol 2007;27:58-61.
40. Galvan FH, Burnam MA, Bing EG. Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. J Psychoactive Drugs 2003;35(Suppl 1):153-160
41. Li X, Margolick JB, Conover CS, Badri S, Riddler SA, Witt MD, Jacobson LP. Interruption and discontinuation of highly active antiretro-viral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2005;38:320-328
42. Centers for Disease Control and Prevention (CDC). HIV/AIDS Surveillance Report. Vol 17 (2005). Atlanta, GA: Centers for Disease Control; 2006.
43. Reif S, Geonnotti KL, Whetten K. HIV infection and AIDS in the Deep South. Am J Public Health 2006;96:970-973
44. American Psychological Association. The Behavioral Health Care Needs of Rural Women. The Report of the Rural Women's Work Group of the Rural Task Force of the American Psychological Association and the American Psychological Association's Committee on Rural Health 2001. Atlanta, GA: Centers for Disease Control; 2006.
45. Karon JM, Fleming PL, Steketee RW, De Cock KM. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001;91:1060-1068
46. Institute of Medicine. No Time to Lose: The AIDS Crisis Is Not Over: Getting More from HIV Prevention. Washington, DC: National Academy Press 2001.
47. Kelly JA, Murphy DA, Bahr GR, Koob JJ, Morgan MG, Kalichman SC, Stevenson LY, Brasfield TL, Bernstein BM, St Lawrence JS. Factors associated with severity of depression and high-risk sexual behavior among persons diagnosed with human immunodeficiency virus (HIV) infection. Health Psychol 1993;12:215-219